KPCB XV Associates, LLC Q2 2022 holdings

$54.2 Million is the total value of KPCB XV Associates, LLC's 4 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
RAPT  Rapt Therapeutics, Inc.$23,671
-17.0%
1,297,0630.0%43.66%
+18.3%
TWLO  Twilio Inc.$15,928
-49.1%
190,0470.0%29.38%
-27.5%
ATRA  Atara Biotherapeutics, Inc.$14,619
-16.1%
1,876,6500.0%26.96%
+19.5%
AUGX  Augmedix, Inc.$1
-50.0%
7080.0%0.00%
-33.3%

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Susan Biglieri — Attorney-in-Fact

Compare quarterly holdings

Export KPCB XV Associates, LLC's holdings

EDGAR filings